Skip to main content
. 2023 Mar 31;14:1135726. doi: 10.3389/fendo.2023.1135726

Table 1.

Profiles of exposure and outcomes in GWAS datasets.

Outcome GWAS ID Consortium Sample Size Number of Cases Number of Controls Year Adjustment Population
sepsis ieu-b-4980 UK Biobank 486,484 11,643 474,841 2021 BMI, COPD, fatigue, arteritis, vaginitis, urolithiasis, depression, immunocompromised, LIDI, ISD European
ALRIs finn-b-J10_LOWERINF FinnGen biobank 218,792 10,103 208,689 2021
IIs finn-b-AB1_VIRAL_OTHER_INTEST_INFECTIONS FinnGen biobank 201,463 4,165 197,298 2021
GUTIs in pregnancy finn-b-O15_PREG_GU_INFECT FinnGen biobank 111,731 1,401 110,330 2021
SSTIs finn-b-L12_INFECT_SKIN FinnGen biobank 218,792 10,343 208,449 2021
UTIs ukb-b-8814 MRC-IEU 463,010 5,447 457,563 2018
Exposure GWAS ID Consortium Sample Size Number of Cases Number of Controls Year nSNP Population
T1DM ebi-a-GCST010681 EBI database 24,840 9,266 15,574 2020 12,783,129 European

GWAS, genome-wide association study; ID, identity; nSNP, number of single nucleotide polymorphism; ALRIs, acute lower respiratory infections; IIs, intestinal infections; GUTIs, infections of genitourinary tract; SSTIs, infections of the skin and subcutaneous tissue; UTIs, urinary tract infections; T1DM, type 1 diabetes mellitus; BMI, body mass index; COPD, chronic obstructive pulmonary disease; LIDI, Long-standing illness, disability or infirmity; ISD, Inflammatory skin disease; UK, United Kingdom; MRC-IEU, Medical Research Council Integrative Epidemiology Unit; EBI, European Bioinformatics Institute.